LUCD Earnings Date: Nov 11, 2026 (Estimated) — Lucid Diagnostics Inc.
NASDAQ · Healthcare · Medical Devices
Updated
When is LUCD's next earnings date?
Lucid Diagnostics Inc. (LUCD) is expected to report Q3 2026 earnings on Wednesday, November 11, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.04 on revenue of $1.6M.
How did LUCD do in its last earnings report?
In its most recent report on Aug 13, 2026, Lucid Diagnostics Inc. posted EPS of -$0.06 versus the -$0.06 estimate, a miss of 5.8%. Revenue was $1.5M against a $1.4M estimate. The stock's 1-day post-earnings move was -1.7%.
How much does LUCD stock move after earnings?
LUCD beat EPS estimates in 1 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 2.7% (up or down) in the day after earnings.
About Lucid Diagnostics Inc.
Lucid Diagnostics Inc. is a commercial-stage medical technology firm focused on diagnostic solutions. The company's primary objective is to serve patients afflicted with gastroesophageal reflux disease (GERD), commonly referred to as chronic heartburn or acid reflux, especially those at increased risk of developing precancerous esophageal conditions or the particularly aggressive esophageal adenocarcinoma. Their key product offerings include EsoGuard, an internally developed esophageal DNA test, and EsoCheck, a specialized device designed for collecting esophageal cells. Formed in 2018, Lucid Diagnostics Inc. has its headquarters in New York, New York, and operates as a subsidiary of PAVmed Inc.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | -0.06 | -0.06 | -5.82% | $1.5M | ❌ Miss | -1.70% | +2.60% | -20.47% | |
| 2026-08-12 | Q2 2026 | -0.05 | -0.08 | -60.00% | $1.5M | ❌ Miss | -1.98% | +2.60% | -20.47% |
| 2026-05-14 | Q1 2026 | -0.06 | -0.07 | -16.67% | $1.3M | ❌ Miss | +0.00% | -1.96% | -5.81% |
| 2026-03-26 | Q4 2025 | -0.08 | -0.10 | -25.00% | $1.5M | ❌ Miss | -3.36% | -3.36% | -10.08% |
| 2025-11-12 | Q3 2025 | -0.08 | -0.10 | -25.00% | $1.2M | ❌ Miss | +6.73% | +0.96% | +9.62% |
| 2025-08-13 | Q2 2025 | -0.10 | -0.10 | +0.00% | $1.2M | ➖ Inline | -1.64% | -0.38% | +7.27% |
| 2025-03-24 | Q4 2024 | -0.15 | -0.19 | -26.67% | $1.2M | ❌ Miss | -1.32% | +3.95% | -15.79% |
| 2024-11-13 | Q3 2024 | -0.22 | -0.20 | +9.09% | $1.2M | ✅ Beat | +5.00% | -4.42% | -22.60% |
Showing last 8 quarters.